Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Other Operating Expenses: 2014-2024

Historic Other Operating Expenses for Theravance Biopharma (TBPH) over the last 6 years, with Sep 2024 value amounting to $1.6 million.

  • Theravance Biopharma's Other Operating Expenses was N/A to $1.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$33.0 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is N/A change from last year.
  • Theravance Biopharma's Other Operating Expenses amounted to $1.6 million in Q3 2024, which was down 47.07% from $3.0 million recorded in Q2 2024.
  • In the past 5 years, Theravance Biopharma's Other Operating Expenses registered a high of $3.8 million during Q2 2022, and its lowest value of -$37.5 million during Q3 2022.
  • In the last 2 years, Theravance Biopharma's Other Operating Expenses had a median value of $1.4 million in 2022 and averaged -$4.7 million.